DB15452Experimental
Technetium Tc-99m epratuzumab is under investigation in clinical trial NCT00003337 (Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma).
- Also known as
- TECHNETIUM TC 99M EPRATUZUMAB
Resolves to
Compound
Which companies are running trials of Technetium Tc-99m epratuzumab, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account